People with certain kinds of blood and lymph cancers can participate in groundbreaking research at Providence Cancer Center in Portland. The center, which focus in part on immunotherapy, is the first site in the nation to test a new non-chemotherapy treatment for patients with B-cell non-Hodgkin's lymphoma or chronic lymphocytic leukemia.

The trials involve a drug that coats cancer cells, making them more visible to the immune system, plus a compound that stimulates the immune system.

“We are seeing more and more evidence that the answer to successfully fighting cancer lies in immunotherapy," says Dr. John Godwin, who will head the trial.  
Four other sites will be carrying out similar trials, which are being sponsored by drug maker Bristol-Myers Squibb.

Patients interested in the trial can contact Laurie Delanty Miller, RN, Providence Cancer Center, at 503-215-2492 or [email protected]